ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Avacta to Launch SARS-CoV-2 ELISA Laboratory Test americanpharmaceuticalreview
September 17, 2020Avacta, the developer of Affimer? biotherapeutics and reagents, has announced it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19. -
Avacta to Launch SARS-CoV-2 ELISA Lab Test contractpharma
September 17, 2020To make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus.
Pharma Sources Insight January 2025
